Useful resources |
Dipyridamole for preventing stroke and other vascular events in patients with vascular disease (Cochrane Review) ABSTRACT Background: Patients with limited cerebral ischaemia of arterial origin are at risk of serious vascular events (4% to 11% annually). Aspirin reduces that risk by 13%. In one trial, adding dipyridamole to aspirin was associated with a 22% risk-reduction compared . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |